Narayana Hrudayalaya Ltd.
Snapshot View

492.20 -8.00 ▼-1.6%

26 July 2021, 04:02:11 P.M.
Volume: 176,779

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.narayanahealth.org
Financial Indicators
Market Cap 10,066.81 Cr.
Earnings per share (EPS) -0.70 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 225.80 Trailing Twelve Months Ending 2021-03
Book Value / Share 54.82 Trailing Twelve Months Ending 2021-03
Price to Book Value 8.99 Calculated using Price: 492.60
Dividend Yield 0.20 Period Ending 2020-03
No. of Shares Subscribed 20.44 Cr. 204,360,804 Shares
FaceValue 10
Company Profile

Narayana Hrudayalaya Limited was incorporated on July 19, 2000 under the Companies Act, 1956. The Company, headquartered in Bengaluru is engaged in providing economical healthcare services. The Company was rebranded as ‘Narayana Health’ in 2013. It has a network of multispecialty and superspeciality hospitals spread across multiple locations.

The company was founded by its Promoter Devi Prasad Shetty, who has over 30 years of medical experience, including as a cardiac surgeon. The company is headquartered in Bengaluru, India, and operates a national network of hospitals in India with a particularly strong presence in the southern state of Karnataka and eastern India, as well as an emerging presence in western and central India. The company’s ‘Narayana Health’ brand is strongly associated with its mission to deliver high quality and affordable healthcare services to the broader population by leveraging its economies of scale, skilled doctors, and an efficient business model.

Business area of the company

The company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals.

Products and Services

  • Anaesthesia & Critical Care
  • Blood Bank
  • Bone Marrow Transplant
  • Breast Cancer
  • Cardiac Surgery - Adult
  • Cardiology - Adult
  • Clinical Nutrition & Dietetics
  • Cranio-Maxillo Facial Surgery
  • Dental Sciences
  • Dermatology and Cosmetology
  • Developmental Medicine
  • Diabetology
  • E.N.T
  • Electrophysiology
  • Emergency Medicine
  • Endocrinology
  • Family Medicine
  • Gastroenterology - Medical
  • Gastroenterology - Surgical
  • Gastrointestinal Oncology
  • General Surgery
  • Genetics
  • Geriatrics
  • Gynaecology - Oncology
  • Haemato Oncology
  • Haematology
  • Head & Neck Surgery - Oncology
  • Heart Transplant
  • Infectious Diseases
  • Integrative Oncology
  • Internal Medicine
  • Interventional Radiology
  • Kidney Transplant - Adult
  • Lab
  • Liver Transplant & HPB Surgery
  • Medical Oncology
  • Microbiology
  • Nephrology
  • Neurology
  • Neurosurgery
  • NICU & PICU
  • Nuclear Medicine
  • Obstetrics & Gynaecology
  • Oncology
  • Ophthalmology
  • Ortho - Oncology
  • Orthopaedics
  • Pain & Palliation - Oncology
  • Pathology
  • Physical Medicine and Rehabilitation
  • Physiotherapy & Rehabilitation
  • Plastic Surgery
  • Psychiatry & Clinical Psychology
  • Pulmonology
  • Radiation Oncology
  • Radiology
  • Reproductive Medicine
  • Rheumatology
  • Robotic Surgery
  • Speech And Swallow Rehabilitation
  • Spine Surgery
  • Surgical Oncology
  • Thoracic Surgery
  • Uro - Oncology
  • Urology
  • Vascular Surgery

Awards

2010:

  • Awarded as the Best Single Speciality Hospital - Cardiology at 'India Healthcare Awards 2010'

2011:

  • A proud recipient of the “India Shining Star CSR Award' for the exceptional CSR work in the health sector

2012:

  • FICCI Health Care Excellence Award
  • Frost and Sullivan India Healthcare Excellence Awards

2013:

  • Financial Times Arcelor Mittal Boldness in Business Awards
  • Inc. India Innovative 100 Award

2014:

  • Narayana health was recognised among world’s top 50 ‘BCG Local Dynamos 2014’ for its exceptional operational efforts.
  • Gold Award winner in Customer Service by Asian Hospital Management Awards
  • Winner of ABP News Brand Excellence Award 2014

2015:

  • Identified for its exceptional work in the department of cardiology, NICS has been named the Best Single Specialty Hospital in India, Cardiology in the CNBC TV 18 & ICICI Lombard India Healthcare Award 2015-16
  • Recognized for its technology enabled innovative primary healthcare services to people living in resource deprived locations in India, Narayana Health has been awarded Public Health Champion Award by WHO India under the category of Innovation
  • NH receives the Healthcare Leadership Awards by Stars of the Industry Group in 2 categories; Outstanding Achievement Awards Healthcare - Social Cause, Healthcare & Social Care Support Award

2016:

  • Health Brand of the Year - Healthcare - India Health & Wellness Awards
  • Quality beyond Accreditation for NH Jaipur at the Global Conclave of Association of Health Care Providers India (AHPI)

2017:

  • Narayana Health was recognized as one of the Best Asian Healthcare Brands by the Economic Times, for its immense contributions & unique initiatives to improve the healthcare industry.
  • Best Cardiac Science Institute of the Year
  • Narayana Superspeciality Hospital Howrah was recognized as the Best Superspeciality Hospital of the Year (Oncology) at the International Healthcare Awards 2017 - country's most authoritative Summit & Awards for the healthcare industry.

2018:

  • Narayana Health won the Silver in Reproductive and Sexual Health Category at India Health & Wellness Summit and Awards.
  • Narayana Health listed in Fortune India 500
  • CSR Excellence in Healthcare

Milestones

  • 2000: Commenced operations from NICS in Bengaluru
  • 2008: The company entered into an investment agreement with the investor Selling Shareholders for the purpose of subscription by the investor Selling Shareholders to 75,414 Equity Shares of Rs 10 each of the company (in the aggregate) for a purchase price of Rs 53,040.55 (approximately) per share, including share premium of Rs 53,030.55 (approximately) per share.
  • 2014: Acquired AHDL.
  • 2014: Acquired the Jubilant Kalpataru Hospital, Barasat, West Bengal.
  • 2014: The company entered into a securities subscription agreement with CDC Group and CDC IOL for subscription to its equity shares and OCDs aggregating to around Rs 300 crore.
  • 2015: Obtained JCI accreditation for HCCI's multispecialty hospital in Cayman Islands.
  • 2018: Narayana Health City Launches ‘Senior Citizen’s Privilege Card’
  • 2018: Narayana Superspeciality Hospital empaneled with CGHS & NHPC
  • 2019: Narayana Health Guwahati opens Day care dialysis center.
  • 2019: Narayana Multispeciality Hospital Launches A Comprehensive Weight Loss Clinic : 1st In Mysore
  • 2019-20: SRCC Children’s Hospital, Mumbai completed 1,000 paediatric cardiac surgeries since its inception strengthening facility’s position as a top-notch medical destination for paediatric treatment
  • 2019-20: Foundation stone laid for setting up a comprehensive Radiation Centre at Health City Cayman Islands
  • 2019-20: Company signed a 3-year contract to deploy and manage NH’s Proprietary Data Intelligence Platform - MEDHA for a PanIndia Hospital Group

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-1.60%
1 Week
+0.24%
1 Month
+3.36%
3 Month
+24.17%
6 Month
+6.98%
1 Year
+68.07%
2 Year
+119.83%
5 Year
+70.25%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 5.16 4.49 6.27 0.88 5.19 9.96 5.67 5.87 11.08
Return on Capital Employed (%) 7.92 7.19 10.21 6.36 9.37 14.77 9.25 9.46 13.80
Return on Assets (%) 3.46 2.73 3.34 0.47 2.91 5.68 2.68 2.39 4.44

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 515 547 580 768 876 963 1,036 1,081 1,136
Non Curr. Liab. 139 214 261 258 365 361 981 1,041 1,152
Curr. Liab. 127 197 312 343 315 323 510 510 600
Minority Int. 2 5 3 1 0 0 0 0 1
Equity & Liab. 783 963 1,156 1,370 1,556 1,647 2,528 2,633 2,889
Non Curr. Assets 654 787 917 1,110 1,270 1,345 2,048 2,106 2,303
Curr. Assets 129 176 239 260 286 302 479 527 586
Misc. Exp. not W/O
Total Assets 783 963 1,156 1,370 1,556 1,647 2,528 2,633 2,889

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 658 839 1,095 1,364 1,614 1,878 2,281 2,861 3,128
Other Income 3 15 22 8 16 23 19 19 28
Total Income 661 854 1,118 1,372 1,630 1,902 2,300 2,880 3,156
Total Expenditure -574 -756 -972 -1,238 -1,437 -1,649 -2,061 -2,566 -2,701
PBIDT 86 99 145 133 193 252 239 314 455
Interest -11 -19 -31 -45 -33 -28 -55 -81 -94
Depreciation -37 -46 -57 -68 -76 -80 -100 -137 -186
Taxation -13 -10 -21 -15 -30 -52 -29 -34 -42
Exceptional Items -11 -1 1 -11
PAT 26 24 35 6 43 91 56 62 122

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 53 45 110 77 174 219 182 279 443
Cash Fr. Inv. -92 -147 -168 -222 -150 -146 -534 -161 -189
Cash Fr. Finan. 38 108 57 140 18 -45 315 -27 -247
Net Change 0 6 -1 -5 42 28 -36 90 8
Cash & Cash Eqvt 18 24 24 21 -11 17 -5 84 92

Shareholding Pattern View Details

9 Qtrs 2019-03 (%) 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%)
Promoter 63.85 63.85 63.85 63.85 63.85 63.85 63.85 63.85 63.85
Public 36.15 36.15 36.15 36.15 36.15 36.15 36.15 36.15 36.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 01 Jul 2021
Trading Window
Narayana Hrudayalaya Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Wed, 30 Jun 2021
Trading Window
Narayana Hrudayalaya Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Fri, 18 Jun 2021
Related Party Transactions
Narayana Hrudayalaya Ltd. has informed the Exchange about related Party Transactions

Technical Scans View Details

Mon, 26 Jul 2021
Stock Outperforming Sectoral Index in both 1 Week and 3 Month Stock Outperforming Sectoral Index in both 1 Week and 3 Month
Strongly Outperforming Benchmark Index Strongly Outperforming Benchmark Index
Strongly Outperforming Sectoral Index Strongly Outperforming Sectoral Index
Close Within 2 Year High Zone Close Within 2 Year High Zone
Close Within 5 Year High Zone Close Within 5 Year High Zone

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 168,769.22 703.40 +1.4%
Divi's Laboratories Ltd. 130,349.05 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. 90,021.63 5,411.25 -0.2%
Cipla Ltd. 76,675.40 950.55 +0.3%
Cadila Healthcare Ltd. 61,992.73 605.55 -1.6%
Apollo Hospitals Enterprise Ltd. 58,965.37 4,100.95 +4.7%
Aurobindo Pharma Ltd. 55,837.02 952.95 -1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 58.12 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 65.69 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.13 5,411.25 -0.2%
Cipla Ltd. Consolidated 2021-03 31.88 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 29.06 605.55 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 392.16 4,100.95 +4.7%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.47 952.95 -1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.63 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 14.02 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.14 5,411.25 -0.2%
Cipla Ltd. Consolidated 2021-03 4.18 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 4.77 605.55 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.83 4,100.95 +4.7%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.55 952.95 -1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 0.18 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 605.55 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,100.95 +4.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 952.95 -1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 10.09 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 605.55 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,100.95 +4.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 952.95 -1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 12.53 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 605.55 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,100.95 +4.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 952.95 -1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 17,131.99 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 605.55 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,100.95 +4.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 952.95 -1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 703.40 +1.4%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,910.15 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 5,411.25 -0.2%
Cipla Ltd. Consolidated 2020-03 1,546.98 950.55 +0.3%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 605.55 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,100.95 +4.7%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 952.95 -1.1%